Showing 501 - 520 results of 101,056 for search '(( 5 ((ht decrease) OR (nn decrease)) ) OR ( 5 ((a decrease) OR (mean decrease)) ))', query time: 1.45s Refine Results
  1. 501
  2. 502
  3. 503
  4. 504
  5. 505
  6. 506

    Anatomical confirmation of drug injection sites. by Diana Amorim (662998)

    Published 2015
    “…<p>Schematic representation of the injection sites in the dorsomedial nucleus of the hypothalamus (DMH) (<b>A-D</b>: -3.00 mm, -3.12 mm, -3.24 mm and -3.36 mm from bregma) and medullary dorsal reticular nucleus (DRt) (<b>E-H</b>: -13.92 mm, -14.04 mm, -14.16 and -14.28 mm from bregma) of SHAM (light dots; n = 7) and ARTH (dark dots; n = 5). …”
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  14. 514
  15. 515
  16. 516

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”
  17. 517

    Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

    Published 2013
    “…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”
  18. 518
  19. 519
  20. 520